Episode 79: Decoding Stargardt: New Treatments, Genetics, and What Lies Ahead

from Talking Euretina · host Whipsmart Media

A landmark Phase 3 trial has delivered the first positive result for Stargardt disease treatment — but the therapeutic landscape is shifting fast. Prof. Maximilian Pfau enjoys a discussion with Prof. Carel Hoyng and Dr. Karolina Kaminska on the ABCA4 disease spectrum, the groundbreaking discovery of AP5 complex-related macular dystrophy, and emerging therapies from oral drugs to gene-specific approaches

Episode metadata supplied by the publisher feed · Published Apr 1, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 79: Decoding Stargardt: New Treatments, Genetics, and What Lies Ahead

0:00 35:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Euretina?

This episode is 35 minutes long.

When was this Talking Euretina episode published?

This episode was published on April 1, 2026.

Can I download this Talking Euretina episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!